mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.05 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.05 |
mRNA |
MK-2206 |
GDSC1000 |
pan-cancer |
AAC |
0.068 |
0.06 |
mRNA |
palmostatin B |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.06 |
mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.06 |
mRNA |
thapsigargin |
GDSC1000 |
pan-cancer |
AAC |
-0.065 |
0.06 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.06 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.06 |
mRNA |
SB-431542 |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.07 |
mRNA |
Nutlin-3 |
CCLE |
pan-cancer |
AAC |
0.084 |
0.07 |